2028

Context: In 2028, R'lyeh Institute commissioned and commenced work on a cutting edge research project, R’lyeh Study 1-890: Targeted Microsphere Cellular Regeneration. The study concluded in 2030, but the results were not made public until 2035. R'lyeh Institute did not comment on the reasons for this secrecy and the apparently lengthy delay in disseminating their findings, given the anticipation within the bio-scientific community. Various theories were proposed by contemporaries working in the field, including the threat of patent infringement, but the consensus appears to be that the study's methodology and use of cutting edge bio-inspired cloning technologies were carried out in a morally and legally grey area. Had such details been made public knowledge, it was believed the likelihood is that the study, despite its major implications for medical science and its vast private funding, would have been shut down or greatly delayed.